Physician profile
Robert Vernooy
NPI 1376644880
$47,011.24
in general payments reported to CMS, 2019-2025
13 companies · $6,363 in 2025
The $6,363 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,134 · 2020: $419 · 2021: $729 · 2022: $14K · 2023: $11K · 2024: $8,027 · 2025: $6,363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $12K · Food and Beverage: $7,106 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,555 · Consulting Fee: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $11,569.34 |
| Food and Beverage | $7,105.98 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,555.00 |
| Consulting Fee | $1,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $22,039.82 | 2019-2025 | Eliquis, Camzyos |
| Medtronic, INC. | $13,147.38 | 2021-2025 | Evera Mri Xt Dr Surescan, Affera Mapping System, Aurora Ev-Icd Mri Surescan |
| Abbott Laboratories | $5,491.87 | 2019-2025 | Amplatzer Amulet, Ensite Precision, Aveir |
| Boston Scientific Corporation | $2,914.99 | 2019-2024 | Ingevity+ |
| Medtronic Vascular, INC. | $1,431.71 | 2019-2020 | |
| Irhythm Technologies, INC. | $1,194.67 | 2021-2024 | Zio Xt Patch, Zio Monitor |
| Biosense Webster, INC. | $391.26 | 2021-2025 | Carto 3 |
| Philips North America LLC | $116.92 | 2020 | |
| Atricure, INC. | $112.23 | 2024 | |
| Pfizer INC. | $99.23 | 2024 | |
| Edwards Lifesciences Corporation | $56.81 | 2020 | |
| Elutia, INC. | $14.35 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$185,923.50 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Vernooy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.